IRIS PubliCatt

Mattiucci, Gian Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.363
EU - Europa 4.180
AS - Asia 798
AF - Africa 33
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 12
Totale 9.414
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.338
DE - Germania 1.755
SE - Svezia 847
CN - Cina 517
IT - Italia 389
UA - Ucraina 326
IE - Irlanda 219
FR - Francia 218
IN - India 133
GB - Regno Unito 119
FI - Finlandia 96
TR - Turchia 71
PL - Polonia 52
BE - Belgio 50
CI - Costa d'Avorio 32
IR - Iran 30
CZ - Repubblica Ceca 26
RU - Federazione Russa 24
CA - Canada 21
NL - Olanda 15
SG - Singapore 15
JP - Giappone 12
AU - Australia 11
EU - Europa 9
CH - Svizzera 7
AT - Austria 6
BR - Brasile 6
CL - Cile 6
NO - Norvegia 6
ES - Italia 5
VN - Vietnam 5
PT - Portogallo 4
RO - Romania 4
HK - Hong Kong 3
KZ - Kazakistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
BZ - Belize 2
GR - Grecia 2
HU - Ungheria 2
KR - Corea 2
LK - Sri Lanka 2
LU - Lussemburgo 2
RS - Serbia 2
TW - Taiwan 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
AL - Albania 1
CM - Camerun 1
DK - Danimarca 1
EC - Ecuador 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
SA - Arabia Saudita 1
VE - Venezuela 1
Totale 9.414
Salva come PNG Salva come JPEG
Città #
Chandler 1.081
Ashburn 379
Jacksonville 224
Dublin 219
Ann Arbor 216
San Mateo 202
Dearborn 145
Nanjing 137
New York 133
Wilmington 131
Woodbridge 117
Boston 106
Nürnberg 92
Milan 85
Marseille 72
Beijing 69
Princeton 69
Bremen 67
Izmir 65
Fairfield 60
Cattolica 57
Lawrence 55
Munich 51
Brussels 50
Warsaw 46
Los Angeles 45
Nanchang 45
Redwood City 43
Seattle 42
Houston 37
Zhengzhou 33
Abidjan 32
Detroit 29
Helsinki 29
Rome 29
Redmond 28
Jiaxing 27
Kunming 27
Leawood 27
Shenyang 27
Boardman 25
Cambridge 21
Norwalk 21
Augusta 20
Changsha 20
Tianjin 20
Hebei 18
Pune 17
University Park 12
Fremont 11
Mountain View 11
Shanghai 11
Ardabil 10
Auburn Hills 10
Hangzhou 10
Washington 10
Falls Church 9
Monmouth Junction 9
Ottawa 9
Andover 8
Chicago 8
Guangzhou 8
Jinan 8
San Diego 8
Amsterdam 7
Berlin 7
Bologna 7
Hefei 7
Kish 7
Ningbo 7
Toronto 7
Albuquerque 6
Bari 6
Dresden 6
Lanzhou 6
Phoenixville 6
San Jose 6
Singapore 6
São Paulo 6
Tettnang 6
Indiana 5
Jinhua 5
Lancaster 5
Landshut 5
Las Vegas 5
London 5
Saint Louis 5
Tokyo 5
Vienna 5
Atlanta 4
Changchun 4
Corato 4
Edinburgh 4
Fuzhou 4
Kocaeli 4
Kraków 4
Mumbai 4
Paderno Franciacorta 4
Paris 4
Sacramento 4
Totale 4.934
Salva come PNG Salva come JPEG
Nome #
EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series 191
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 172
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 164
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 164
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 162
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 156
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 141
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 131
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 131
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 130
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 128
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 127
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 124
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 123
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 122
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 121
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 121
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 120
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 120
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 119
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 118
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 118
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 115
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 112
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 108
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 108
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 107
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 104
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 103
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 102
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 101
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 100
Recurrence in region of spared parotid gland in patient receiving definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A case report 98
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 98
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 97
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 97
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 97
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 97
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 96
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 94
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 94
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 92
Reducing heart dose during left breast cancer radiotherapy: Comparison among 3 radiation techniques 92
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 88
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 87
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 84
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 83
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study 81
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 81
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 79
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 79
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 78
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 78
Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. 77
Locally Advanced Prostate Cancer: Three-Dimensional Magnetic Resonance Spectroscopy to Monitor Prostate Response to Therapy 76
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy 74
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 72
Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience. 70
Can automation in radiotherapy reduce costs? 70
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. 70
Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: Single-institution experience and systematic review 70
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 70
Development of a modelling to correlate site and diameter of brain metastases with hippocampal sparing using volumetric modulated Arc therapy 69
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 67
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 67
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 67
Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas 67
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 65
Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study 64
In reply to Yamazaki et al 63
MITHRA - Multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: A feasibility study 63
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 62
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 61
Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls 61
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 60
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 58
A new frontier of image guidance: Organs at risk avoidance with MRI-guided respiratory-gated intensity modulated radiotherapy: Technical note and report of a case 57
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 56
Hybrid Tri-Co-60 MRI radiotherapy for locally advanced rectal cancer: An in silico evaluation 56
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival 55
Use of Indirect Target Gating in Magnetic Resonance-guided Liver Stereotactic Body Radiotherapy: Case Report of an Oligometastatic Patient 55
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 54
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanning 54
EROS study: Evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis 53
Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy 53
Prostheses irradiation in high risk breast cancer patients: clinical and aesthetic outcomes in retrospective series 52
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 52
Robotic radiosurgery in pancreatic cancer: A systematic review 50
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 49
Adaptive optimization by 6 DOF robotic couch in prostate volumetric IMRT treatment: Rototranslational shift and dosimetric consequences 48
Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation 47
Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study 46
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 46
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 45
Clinical Target Volume in Biliary Carcinoma: A Systematic Review of Pathological Studies. 44
Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model 44
Adjuvant radiotherapy with brachytherapy boost in soft tissue sarcomas 43
Preoperative chemoradiation and intra-operative radiotherapy for pancreatic carcinoma 43
776 poster THE PRELIMINARY RESULTS OF PHASE II STUDY: NEOADJUVANT CHEMOTHERAPY AND LOW-DOSE RADIOTHERAPY FOR BREAST CANCER 43
HDR interventional radiotherapy (brachytherapy) in the treatment of primary and recurrent head and neck malignancies 43
Totale 8.664
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019178 0 0 0 0 0 0 0 0 0 0 110 68
2019/20201.428 215 80 72 46 151 145 146 59 157 70 206 81
2020/2021793 42 86 16 87 125 46 64 20 107 52 133 15
2021/20221.261 121 65 16 127 57 41 21 198 55 102 212 246
2022/20232.796 371 389 220 464 161 336 139 240 323 31 92 30
2023/20241.024 45 340 41 161 46 192 55 89 11 38 6 0
Totale 9.579